Correspondence 0001193125-25-014241 from Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc.
Date: Jan. 28, 2025 · CIK: 0001674632 · Accession: 0001193125-25-014241
AI Filing Summary & Sentiment
File numbers found in text: 333-284147
Letter
BofA Securities, Inc.
One Bryant Park
New York, NY 10036
Piper Sandler & Co.
U.S. Bancorp Center
800 Nicollet Mall, Suite 1000
Minneapolis, MN 55402
Leerink Partners LLC
1301 Avenue of the Americas, 5th Floor
New York, NY 10019
January 28, 2025
VIA EDGAR
Office of Industrial Applications and Services
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C.
Attn: Juan Grana, Lauren Nguyen, Julie Sherman and Jeanne Baker
Re: Beta Bionics, Inc.
Registration Statement on Form S-1, as amended
Filed January 23, 2025
File No. 333-284147
Acceleration Request
Requested Date: January 29,
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), we, as the representatives of the several underwriters (the “Representatives”), hereby join in the request of Beta Bionics, Inc., a Delaware corporation (the “Company”), that the effective date of the above-referenced Registration Statement on Form S-1 be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time, on January 29, 2025, or as soon thereafter as practicable, or at such other time thereafter as the Company or its outside counsel, Cooley LLP, may request by telephone to the staff of the Securities and Exchange Commission.
Pursuant to Rule 460 under the Securities Act, we, as the Representatives, wish to advise you that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others prior to the requested effective time of the Registration Statement.
We, the undersigned Representatives, hereby represent that we are in compliance and will comply, and we have been informed by the other participating underwriters that they are in compliance and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, in connection with the offering pursuant to the above-referenced Registration Statement and Preliminary Prospectus.
[Signature Page Follows]
Very truly yours,
BofA Securities, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP BofA Securities, Inc. One Bryant Park New York, NY 10036 Piper Sandler & Co. U.S. Bancorp Center 800 Nicollet Mall, Suite 1000 Minneapolis, MN 55402 Leerink Partners LLC 1301 Avenue of the Americas, 5th Floor New York, NY 10019 January 28, 2025 VIA EDGAR Office of Industrial Applications and Services Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attn: Juan Grana, Lauren Nguyen, Julie Sherman and Jeanne Baker Re: Beta Bionics, Inc. Registration Statement on Form S-1, as amended Filed January 23, 2025 File No. 333-284147 Acceleration Request Requested Date: January 29, 2025 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), we, as the representatives of the several underwriters (the “Representatives”), hereby join in the request of Beta Bionics, Inc., a Delaware corporation (the “Company”), that the effective date of the above-referenced Registration Statement on Form S-1 be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time, on January 29, 2025, or as soon thereafter as practicable, or at such other time thereafter as the Company or its outside counsel, Cooley LLP, may request by telephone to the staff of the Securities and Exchange Commission. Pursuant to Rule 460 under the Securities Act, we, as the Representatives, wish to advise you that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others prior to the requested effective time of the Registration Statement. We, the undersigned Representatives, hereby represent that we are in compliance and will comply, and we have been informed by the other participating underwriters that they are in compliance and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, in connection with the offering pursuant to the above-referenced Registration Statement and Preliminary Prospectus. [Signature Page Follows] Very truly yours, BofA Securities, Inc. Piper Sandler & Co. Leerink Partners LLC, As Representatives of the several Underwriters BOFA SECURITIES, INC. By: /s/ Michael Liloia Name: Michael Liloia Title: Director PIPER SANDLER & CO. By: /s/ Neil Riley Name: Neil Riley Title: Managing Director LEERINK PARTNERS LLC By: /s/ Patrick Morley Name: Patrick Morley Title: Senior Managing Director [Signature Page to Underwriters’ Acceleration Request Letter]